Shingrix
Vaccines upstart Curevo has designs on blockbuster GSK franchise
Phil Taylor
Curevo, financing, GlaxoSmithKline, shingles, Shingrix, vaccine
0 Comment
Look out GSK, Pfizer and BioNTech are coming for Shingrix
Phil Taylor
GlaxoSmithKline, mRNA, partnering, Pfizer, shingles, Shingrix, vaccine
0 Comment
GSK wants to double Shingrix sales, and a new FDA okay could help
Phil Taylor
GlaxoSmithKline, regulatory approval, shingles, Shingrix
0 Comment
News/ News/ Sales and Marketing
Vaccine sales recover at GSK in Q3, but lockdown fears weigh on shares
Phil Taylor
coronavirus, coronavirus vaccine, COVID-19, financial results, GlaxoSmithKline, Shingrix, Trelegy
0 Comment
News/ News/ Sales and Marketing
GSK starts 2020 on a high, but warns of tougher times ahead
Phil Taylor
coronavirus, financial results, GlaxoSmithKline, Shingrix, Zejula
0 Comment
News/ News/ Sales and Marketing
Shingrix and Trelegy shield GSK from Advair fallout
Phil Taylor
Advair, financial results, GlaxoSmithKline, Nucala, Shingrix, Trelegy
0 Comment
News/ News/ Sales and Marketing
Shingles vaccine boosts GSK as generic Advair bites
George Underwood
Advair, GlaxoSmithKline, GSK, Q1, Shingrix
0 Comment
Healthcare/ Market Access/ News/ News/ Pharma Market Access/ US